InvestorsHub Logo
icon url

joseytheoutlawwales

07/08/17 2:44 PM

#264304 RE: tombe #264291

Elites timing for approval and market niche, being early, is dwindling every day.
Every single BP will have ADT in its arsenal in the near future, the only question is whether ELTP will get on the ball and 'git 'er done' or fade into obscurity.

I'm frankly disappointed in management, and think a change there is needed to some degree; even if only in terms of communication and transparency. Science can be solid, but fail if mismanaged.
icon url

The ELTP King

07/08/17 3:21 PM

#264325 RE: tombe #264291

Agreed.

It's extremely tough to create an ART IR product.

Given ALL opioids are to transition to abuse-deterrent the FDA will have to let companies use labels instead like they have done in the past.

It is really gonna suck when a couple years down the road comes the first IR drug approved with similar Tmax complete with labeling.